CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Clinical trial NCT03291444 · UNKNOWN

Trial details

NCT number: NCT03291444
Sponsor: Zhujiang Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Acute Lymphocytic (ALL)Leukemia, Acute Myelogenous (AML)Myelodysplastic Syndromes

Start date: 2018-05-05
Primary completion: 2024-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.